Concepedia

Sara S. Bashraheel

SS

5

Publications

82

Citations

5

H-Index

2018

Active since

Affiliations

Cairo University(Current)

University of Groningen

Anti-Doping Laboratory

Xi’an Jiaotong-Liverpool University

University Medical Center Groningen

Sara S. Bashraheel is an author at Cairo University specializing in drug discovery, cancer therapeutics, and medicine.

ORCID

Top concepts

Publications per year

2018–2020

5

Publications

5

Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment

Alanod D. AlQahtani, Layla Al-Mansoori, Sara S. Bashraheel et al. · European Journal of Pharmaceutical Sciences · 2018 · 28 citations

, , +8

Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment

Fatma B. Rashidi, Alanod D. AlQhatani, Sara S. Bashraheel et al. · PLoS ONE · 2018 · 20 citations · Full text

, , +20

Production of “biobetter” variants of glucarpidase with enhanced enzyme activity

Alanod D. AlQahtani, Sara S. Bashraheel, Fatma B. Rashidi et al. · Biomedicine & Pharmacotherapy · 2019 · 13 citations · Full text

<i>In vitro</i>studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy

Layla Al-Mansoori, Sara S. Bashraheel, Alanod D. Al Qahtani et al. · Oncotarget · 2020 · 11 citations · Full text

Studies on vascular response to full superantigens and superantigen derived peptides: Possible production of novel superantigen variants with less vasodilation effect for tolerable cancer immunotherapy

Sara S. Bashraheel, Alanod D. AlQahtani, Fatma B. Rashidi et al. · Biomedicine & Pharmacotherapy · 2019 · 10 citations · Full text

Rows per page

1–5 of 5